|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2000-12-21
|
|
pubmed:abstractText |
To compare the overall efficacy of combination therapies focused on fasting or postprandial blood glucose in patients with type 2 diabetes not adequately controlled with oral sulfonylurea agents alone.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0149-5992
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1236-41
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10977012-Blood Glucose,
pubmed-meshheading:10977012-Diabetes Mellitus, Type 2,
pubmed-meshheading:10977012-Drug Administration Schedule,
pubmed-meshheading:10977012-Drug Therapy, Combination,
pubmed-meshheading:10977012-Fasting,
pubmed-meshheading:10977012-Female,
pubmed-meshheading:10977012-Glyburide,
pubmed-meshheading:10977012-Hemoglobin A, Glycosylated,
pubmed-meshheading:10977012-Humans,
pubmed-meshheading:10977012-Hypoglycemic Agents,
pubmed-meshheading:10977012-Insulin,
pubmed-meshheading:10977012-Insulin, Isophane,
pubmed-meshheading:10977012-Insulin Lispro,
pubmed-meshheading:10977012-Male,
pubmed-meshheading:10977012-Middle Aged,
pubmed-meshheading:10977012-Postprandial Period
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.
|
|
pubmed:affiliation |
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. ejbIII@lilly.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
